Autoimmune Diseases  >>  NovoLog (insulin aspart)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NovoLog (insulin aspart) / Novo Nordisk
NCT00604656: Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes

Completed
3
241
Europe
insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
01/04
01/04
NCT00071448: Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

Completed
3
378
US
insulin human, insulin lispro, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
06/04
06/04
NCT00097071: Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents

Completed
3
299
US
insulin lispro, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
05/06
05/06
iINHALE 9, NCT00523042 / 2006-004622-81: Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Terminated
3
10
US, Europe, RoW
insulin aspart, NovoRapid®, NovoLog®, inhaled human insulin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Asthma
02/08
02/08
NCT00888732 / 2008-007176-22: A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin

Completed
3
24
Europe
Insulin Aspart, BIAsp 70, BIAsp50, Human Insulin, - Insulin Aspart: NovoRapid, - BIAsp 50: NovoMix 50, - BIAsp 70: NovoMix 70, - Human Insulin: Actrapid
University of Aarhus, Novo Nordisk A/S
Diabetes Mellitus, Type 1
06/10
06/10

Download Options